Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Shilpa Medicare's 238% Rally Faces An Earnings Test

    22 hours ago

    Shilpa Medicare is scaling formulations, biologics, peptides and CDMO alongside its core API business, with Q1FY27 revenue and profit reaching record levels. After a 238% gain in 2026, the focus is shifting to whether its pipeline and new capacity can sustain earnings growth.
    Click here to Read More
    Previous Article
    UPI MDR: Opposition Allegations Not True, It Won't Be Passed On To Customers, Says FM Sitharaman
    Next Article
    Airbus Grappling With Fresh Quality Issue On A321 Jet Model

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment